The Cystic Fibrosis Foundation has awarded a milestone payment totaling $645,000 to Hollis-Eden Pharmaceuticals. The company earned the payment by meeting specific development milestones under an existing collaboration agreement with the Foundation to develop novel, anti-inflammatory therapies for people with CF.
Dec. 28, 2007
|
1 min read
Share this article
Topics
About the CF Foundation
|
Drug Pipeline
Cystic Fibrosis Community Perspectives Influence Future of CF Care Model
News |
4 min read
CF Foundation Adapts Registry Reporting to New Race-Neutral Standards
News |
5 min read
Nearly 350 Advocates Urge Congressional Action During 17th Annual March on the Hill
News |
3 min read
Stay up to date with The Foundation
Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.